Preview

Vestnik SurGU. Meditsina

Advanced search

RUSSIAN PRACTICING VASCULAR SURGEON SCLEROTHERAPY COMPLICATION RATE SURVEY RESULTS

Abstract

The study objective is the estimation of complication rate after various sclerotherapy options. The data have been acquired through a Russian practicing vascular surgeon survey. The study is based on an anonymous survey by the Russian Association of Vascular Surgeons. 200 forms, 7 questions each, have been mailed, 71 filled forms have been returned. The survey shoes that a set of certain complications routinely accompanies sclerotherapy surgeons. The leading complications are metting (reported by 96.8 % survey respondents) and hyperpigmentation (reported by 96.1 % survey respondents). Out of the stochastic complications the most common one is deep vein thrombosis reported by 30.2 % respondents.

About the Authors

K. V. Mazayshvili
Surgut State University; Antireflux Vascular Surgery Center
Russian Federation


S. Y. Kharitonova
Pirogov National Medical Surgery Center
Russian Federation


A. V. Tsyplyashchyk
Pirogov National Medical Surgery Center
Russian Federation


References

1. Баешко А. А. Пенная склеротерапия: история развития и современные данные // Новости хирургии. 2012. Т. 20. № 4. С. 101-110.

2. Беленцов С. М. Эхо-Foam-склеротерапия как метод устранения патологических рефлюксов при варикозной болезни нижних конечностей: ближайшие и отдаленные результаты //Ангиология и сосудистая хирургия. 2007. Т. 13. № 2. С. 57-60.

3. Шевкуненко В. Н. Курс оперативной хирургии с анатомо-топографическими данными. М. : ОГИЗ, 1935. 448 с.

4. Константинова Г. Д. Практикум по лечению варикозной болезни. М. : Профиль, 2006. 191 с.

5. Bergan J. J., Bunke-Pacuette N. The Vein Book. New York : Oxford University Press, 2014. 568 p.

6. Bihari I. Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections // Orv Hetil. 2007. Vol. 148. № 2. P. 51-58.

7. Woolman J., Bergan J., Van Le Chang. History of sclerosants foams: persons, techniques, patents and medical improvements // Foam sclerotherapy. London : Royal Society of Medicine Press, 2008.

8. Дан В. Н., Сапелкин C. B. Ангиодисплазии: врожденные пороки развития сосудов. М. : Веранда, 2008. С. 157-161.

9. Серажитдинов А. Ш. Стволовая склеротерапия варикозной болезни нижних конечностей с помощью фибро-вейна // Новые технологии в медицине : тр. междунар. науч.-практич. конф. Трехгорный, 1998. C. 120-121.

10. Allaf N., Welch M. Recurrent varicose veins: inadequate surgery remains a problem // Phlebology. 2000. Vol. 20. № 3. P. 138-140.

11. Hill D., Hamilton R., Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein // J Vasc Surg. 2008. Vol. 48. P. 934-93.

12. Regan J. D. Safety of proprietary sclerosant microfoam for saphenous incompetence in patients with R-to L shunt: interim report // J Vasc Interv Radiol. 2008. Vol. 19. Suppl. Р. 35.

13. Кириенко А. И. Хроническая венозная недостаточность нижних конечностей: принципы лечения // Справочник поликлинич. врача. 2006. № 1. С. 90-94.

14. Cabrera J. R. Extending the Limits of Sclerotherapy: New Sclerosing Products // Phlébologie. 1997. Vol. 50. № 2. P. 181-188.

15. De Zeeuw R. Ultrasound guided foam sclerotherapy in the treatment of varicose veins: tips and tricks // Phlebology. 2005. Vol. 20. P. 159-162.

16. Peterson J. D., Goldman M. P. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study // Phlebology. 2012. Vol. 27. P. 73-76.

17. Дибиров М. Д., Шиманко А. И. [и др.] Варикозная болезнь вен нижних конечностей у больных пожилого и старческого возраста // Клинич. геронтология. 2006. Т. 6. № 12. С. 47-52.

18. Сabrera Garrido J. Los esclerosantes en microespuma contra 1 patologia venosa // Noticias Med. 1997. Vol. 3. P. 12-16.

19. Guex J. J. Complications and side-effects of foam sclerotherapy // Phlebology. 2009. Vol. 24. P. 270-274.

20. Guex J. J., Allaert F. A., Gillet J. L., Chleir F. Immediate and midterm complications of sclerotherapy. Report of a prospective multicenter registry of 12,173 sclerotherapy sessions. // Dermatol Surg. 2005 № 31. P. 123-128.

21. Guex J. J., Schliephake D. E., Otto J., Mako S., Allaert F. A. The French Polidocanol study on long term side effects. A survey covering 3357 patients years // Dermatol Surg. 2009. V. 36. Suppl 2. P. 993-1003.

22. Gillet J. L., Guedes J. M., Guex J. J. et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins : a controlled multicentre prospective study including 1025 patients // Phlebology. 2009. № 24. P. 131-138.

23. Forlee M. V., Grouden M., Moore D. J., Shanik G. Stroke after varicose vein foam injection sclerotherapy // J Vasc Surg. 2006. № 43. P. 162-164.

24. Busch R. G., Derrick M., Manjoney D. Major neurological events following foam sclerotherapy // Phlebology. 2008. № 23. P. 189-192.

25. Perrow Ch. Normal Accidents: Living with High Risk Technologies. Princeton University Press, 1999.


Review

For citations:


Mazayshvili K.V., Kharitonova S.Y., Tsyplyashchyk A.V. RUSSIAN PRACTICING VASCULAR SURGEON SCLEROTHERAPY COMPLICATION RATE SURVEY RESULTS. Vestnik SurGU. Meditsina. 2017;(2 (32)):45-49. (In Russ.)

Views: 181


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2949-3447 (Online)